nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—AGTR1—blood plasma—schizophrenia	0.0191	0.141	CbGeAlD
Valsartan—SLCO1B1—blood plasma—schizophrenia	0.0182	0.135	CbGeAlD
Valsartan—CYP2C9—urine—schizophrenia	0.0176	0.13	CbGeAlD
Valsartan—AGTR1—forebrain—schizophrenia	0.0105	0.0774	CbGeAlD
Valsartan—SLCO1B3—endocrine gland—schizophrenia	0.01	0.074	CbGeAlD
Valsartan—CYP2C9—blood plasma—schizophrenia	0.0092	0.068	CbGeAlD
Valsartan—Irbesartan—CYP1A2—schizophrenia	0.00769	0.236	CrCbGaD
Valsartan—AGTR1—blood—schizophrenia	0.007	0.0517	CbGeAlD
Valsartan—Losartan—ACE—schizophrenia	0.00698	0.215	CrCbGaD
Valsartan—SLCO1B1—blood—schizophrenia	0.00667	0.0493	CbGeAlD
Valsartan—AGTR1—endocrine gland—schizophrenia	0.00607	0.0449	CbGeAlD
Valsartan—Irbesartan—CYP2D6—schizophrenia	0.00593	0.182	CrCbGaD
Valsartan—SLCO1B1—endocrine gland—schizophrenia	0.00579	0.0428	CbGeAlD
Valsartan—AGTR1—nervous system—schizophrenia	0.00568	0.042	CbGeAlD
Valsartan—AGTR1—central nervous system—schizophrenia	0.00547	0.0404	CbGeAlD
Valsartan—Losartan—CYP1A2—schizophrenia	0.00495	0.152	CrCbGaD
Valsartan—AGTR1—brain—schizophrenia	0.00434	0.0321	CbGeAlD
Valsartan—Candesartan—ABCB1—schizophrenia	0.00424	0.13	CrCbGaD
Valsartan—CYP2C9—blood—schizophrenia	0.00337	0.0249	CbGeAlD
Valsartan—ALB—brain—schizophrenia	0.00335	0.0248	CbGeAlD
Valsartan—CYP2C9—endocrine gland—schizophrenia	0.00292	0.0216	CbGeAlD
Valsartan—Losartan—ABCB1—schizophrenia	0.00273	0.0839	CrCbGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ATP2A2—schizophrenia	0.000697	0.000838	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC1A1—schizophrenia	0.000694	0.000834	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MAG—schizophrenia	0.00069	0.000829	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PNP—schizophrenia	0.000686	0.000825	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—DRD3—schizophrenia	0.000685	0.000823	CbGpPWpGaD
Valsartan—ALB—Vitamin B12 Metabolism—TNF—schizophrenia	0.000683	0.000821	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR7—schizophrenia	0.000682	0.00082	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—DRD2—schizophrenia	0.000682	0.00082	CbGpPWpGaD
Valsartan—ALB—Hemostasis—MAG—schizophrenia	0.000681	0.000819	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000679	0.000815	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PRKD1—schizophrenia	0.000677	0.000813	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—DRD4—schizophrenia	0.000665	0.000799	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—schizophrenia	0.000665	0.000799	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—NDUFV2—schizophrenia	0.000638	0.000767	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—CNR1—schizophrenia	0.000635	0.000763	CbGpPWpGaD
Valsartan—ALB—Metabolism—PRODH—schizophrenia	0.000635	0.000763	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC17A7—schizophrenia	0.000634	0.000762	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CHRM1—schizophrenia	0.000631	0.000758	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	0.00063	0.000757	CbGpPWpGaD
Valsartan—ALB—SLC-mediated transmembrane transport—SLC6A3—schizophrenia	0.000627	0.000753	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—DRD2—schizophrenia	0.00062	0.000744	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR7—schizophrenia	0.00062	0.000744	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—IL3RA—schizophrenia	0.000615	0.000739	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—IL1B—schizophrenia	0.000608	0.000731	CbGpPWpGaD
Valsartan—ALB—Hemostasis—IL3RA—schizophrenia	0.000607	0.00073	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—COMT—schizophrenia	0.000607	0.00073	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—GSTP1—schizophrenia	0.000604	0.000726	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—MAOA—schizophrenia	0.000603	0.000724	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NRG3—schizophrenia	0.0006	0.000721	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TLE1—schizophrenia	0.0006	0.000721	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PIP4K2A—schizophrenia	0.0006	0.000721	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—COMT—schizophrenia	0.000599	0.00072	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—GSTP1—schizophrenia	0.000596	0.000716	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000595	0.000715	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GFAP—schizophrenia	0.000593	0.000713	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GRM5—schizophrenia	0.000586	0.000705	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.000583	0.000701	CbGpPWpGaD
Valsartan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—schizophrenia	0.000572	0.000687	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TLE3—schizophrenia	0.000568	0.000682	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GAPDH—schizophrenia	0.000565	0.000679	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—GABRB2—schizophrenia	0.000563	0.000676	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CLOCK—schizophrenia	0.00056	0.000673	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000558	0.000671	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	0.000558	0.00067	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TNF—schizophrenia	0.000556	0.000668	CbGpPWpGaD
Valsartan—CYP2C9—Biological oxidations—GSTM1—schizophrenia	0.000555	0.000667	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—PLA2G4A—schizophrenia	0.000555	0.000667	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000552	0.000663	CbGpPWpGaD
Valsartan—CYP2C9—Metapathway biotransformation—GSTM1—schizophrenia	0.000548	0.000658	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—TPH2—schizophrenia	0.000545	0.000655	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CACNB2—schizophrenia	0.000545	0.000655	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP26B1—schizophrenia	0.000543	0.000652	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—DPYD—schizophrenia	0.000537	0.000645	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCK—schizophrenia	0.000536	0.000644	CbGpPWpGaD
Valsartan—SLCO1B3—Transmembrane transport of small molecules—APOA1—schizophrenia	0.000525	0.000631	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PDE4B—schizophrenia	0.000523	0.000628	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—YWHAZ—schizophrenia	0.000522	0.000627	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PRODH—schizophrenia	0.00052	0.000624	CbGpPWpGaD
Valsartan—ALB—Metabolism—MPC2—schizophrenia	0.000517	0.000622	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CCKAR—schizophrenia	0.000514	0.000618	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CACNA1C—schizophrenia	0.000499	0.000599	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ADORA2A—schizophrenia	0.000499	0.000599	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—PLA2G4A—schizophrenia	0.00049	0.000589	CbGpPWpGaD
Valsartan—ALB—Folate Metabolism—TP53—schizophrenia	0.00049	0.000589	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PIK3C2A—schizophrenia	0.000486	0.000584	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC18A2—schizophrenia	0.000486	0.000584	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GCLM—schizophrenia	0.000484	0.000581	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TPH1—schizophrenia	0.000484	0.000581	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.000482	0.00058	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLCH2—schizophrenia	0.000481	0.000578	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—FGA—schizophrenia	0.000478	0.000574	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—HTR2A—schizophrenia	0.000478	0.000574	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.000477	0.000574	CbGpPWpGaD
Valsartan—ALB—Hemostasis—FGA—schizophrenia	0.000472	0.000568	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPY—schizophrenia	0.000466	0.00056	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ATP2A2—schizophrenia	0.000466	0.00056	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NOTCH4—schizophrenia	0.000466	0.00056	CbGpPWpGaD
Valsartan—ALB—Hemostasis—ATP2A2—schizophrenia	0.00046	0.000553	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000456	0.000548	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PRKD1—schizophrenia	0.000455	0.000546	CbGpPWpGaD
Valsartan—ALB—Metabolism—NDST3—schizophrenia	0.000452	0.000543	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—APOA1—schizophrenia	0.000452	0.000543	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR1B—schizophrenia	0.000449	0.00054	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—OXT—schizophrenia	0.000449	0.00054	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC6A1—schizophrenia	0.000447	0.000537	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—schizophrenia	0.000447	0.000537	CbGpPWpGaD
Valsartan—ALB—Selenium Micronutrient Network—TNF—schizophrenia	0.000441	0.00053	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP2D6—schizophrenia	0.000436	0.000524	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—SNAP25—schizophrenia	0.000436	0.000524	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—HTR2A—schizophrenia	0.000434	0.000521	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR1A—schizophrenia	0.000433	0.00052	CbGpPWpGaD
Valsartan—ALB—Metabolism—ACSL6—schizophrenia	0.000429	0.000515	CbGpPWpGaD
Valsartan—ALB—Metabolism—SLC27A5—schizophrenia	0.000429	0.000515	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NPS—schizophrenia	0.000426	0.000512	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MPC2—schizophrenia	0.000424	0.000509	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000419	0.000504	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR2C—schizophrenia	0.000418	0.000502	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD1—schizophrenia	0.000418	0.000502	CbGpPWpGaD
Valsartan—ALB—Metabolism—DAO—schizophrenia	0.000409	0.000491	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NTRK2—schizophrenia	0.000406	0.000488	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD3—schizophrenia	0.000405	0.000486	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ATP2A2—schizophrenia	0.000398	0.000479	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.000395	0.000475	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—CYP1A2—schizophrenia	0.000394	0.000474	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLCH2—schizophrenia	0.000394	0.000473	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD4—schizophrenia	0.000393	0.000472	CbGpPWpGaD
Valsartan—ALB—Metabolism—PNP—schizophrenia	0.000392	0.000471	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—TH—schizophrenia	0.000389	0.000467	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GAPDH—schizophrenia	0.000379	0.000456	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CLOCK—schizophrenia	0.000376	0.000452	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000375	0.000451	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—CNR1—schizophrenia	0.000375	0.000451	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000371	0.000446	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NDST3—schizophrenia	0.00037	0.000445	CbGpPWpGaD
Valsartan—ALB—Hemostasis—NOS1—schizophrenia	0.000368	0.000442	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CACNB2—schizophrenia	0.000366	0.00044	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TPH2—schizophrenia	0.000366	0.00044	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—DRD2—schizophrenia	0.000366	0.00044	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR7—schizophrenia	0.000366	0.00044	CbGpPWpGaD
Valsartan—ALB—Metabolism—NDUFV2—schizophrenia	0.000365	0.000438	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—DPYD—schizophrenia	0.000361	0.000433	CbGpPWpGaD
Valsartan—SLCO1B1—Transmembrane transport of small molecules—APOA1—schizophrenia	0.000353	0.000424	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ACSL6—schizophrenia	0.000351	0.000422	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SLC27A5—schizophrenia	0.000351	0.000422	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PRL—schizophrenia	0.000346	0.000415	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.000343	0.000412	CbGpPWpGaD
Valsartan—ALB—Metabolism—PIP4K2A—schizophrenia	0.000343	0.000412	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.00034	0.000408	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CACNA1C—schizophrenia	0.000335	0.000403	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DAO—schizophrenia	0.000335	0.000402	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—COMT—schizophrenia	0.00033	0.000397	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTP1—schizophrenia	0.000329	0.000395	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MAOA—schizophrenia	0.000328	0.000394	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PIK3C2A—schizophrenia	0.000327	0.000392	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—S100B—schizophrenia	0.000322	0.000387	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PNP—schizophrenia	0.000321	0.000386	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—SLC6A3—schizophrenia	0.000319	0.000383	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000318	0.000382	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—ABCB1—schizophrenia	0.000311	0.000374	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP26B1—schizophrenia	0.00031	0.000372	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ERBB4—schizophrenia	0.000308	0.00037	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—PLA2G4A—schizophrenia	0.000302	0.000363	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—GSTM1—schizophrenia	0.000302	0.000363	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—NDUFV2—schizophrenia	0.000298	0.000359	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP2D6—schizophrenia	0.000293	0.000352	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—SNAP25—schizophrenia	0.000293	0.000352	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—PLA2G4A—schizophrenia	0.00029	0.000348	CbGpPWpGaD
Valsartan—ALB—Hemostasis—PLA2G4A—schizophrenia	0.000286	0.000344	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—NRG1—schizophrenia	0.000284	0.000342	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—MEF2C—schizophrenia	0.000282	0.000339	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PIP4K2A—schizophrenia	0.000281	0.000337	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000278	0.000334	CbGpPWpGaD
Valsartan—ALB—Metabolism—TPH1—schizophrenia	0.000276	0.000332	CbGpPWpGaD
Valsartan—ALB—Metabolism—GCLM—schizophrenia	0.000276	0.000332	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—YWHAZ—schizophrenia	0.000272	0.000327	CbGpPWpGaD
Valsartan—ALB—Hemostasis—YWHAZ—schizophrenia	0.000269	0.000323	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—MTHFR—schizophrenia	0.000267	0.000321	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ERBB3—schizophrenia	0.000266	0.00032	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—CYP1A2—schizophrenia	0.000265	0.000318	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—TH—schizophrenia	0.000261	0.000314	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000261	0.000313	CbGpPWpGaD
Valsartan—ALB—Metabolism—PRKD1—schizophrenia	0.00026	0.000312	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—HTR2A—schizophrenia	0.000256	0.000308	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—ABCB1—schizophrenia	0.000255	0.000307	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP26B1—schizophrenia	0.000254	0.000305	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOE—schizophrenia	0.000249	0.000299	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—APOA1—schizophrenia	0.000246	0.000295	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOE—schizophrenia	0.000238	0.000286	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—APOA1—schizophrenia	0.000236	0.000283	CbGpPWpGaD
Valsartan—ALB—Hemostasis—APOA1—schizophrenia	0.000233	0.00028	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—ESR1—schizophrenia	0.000228	0.000273	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TPH1—schizophrenia	0.000226	0.000272	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GCLM—schizophrenia	0.000226	0.000272	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—COMT—schizophrenia	0.000222	0.000267	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTP1—schizophrenia	0.000221	0.000266	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MAOA—schizophrenia	0.00022	0.000265	CbGpPWpGaD
Valsartan—ALB—Metabolism—GAPDH—schizophrenia	0.000217	0.000261	CbGpPWpGaD
Valsartan—ALB—Metabolism—CLOCK—schizophrenia	0.000215	0.000258	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000214	0.000258	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000214	0.000257	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000213	0.000256	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PRKD1—schizophrenia	0.000213	0.000255	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000212	0.000255	CbGpPWpGaD
Valsartan—ALB—Metabolism—TPH2—schizophrenia	0.000209	0.000252	CbGpPWpGaD
Valsartan—ALB—Metabolism—CACNB2—schizophrenia	0.000209	0.000252	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—ABCB1—schizophrenia	0.000209	0.000251	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—GSK3B—schizophrenia	0.000206	0.000248	CbGpPWpGaD
Valsartan—ALB—Metabolism—DPYD—schizophrenia	0.000206	0.000248	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—PLA2G4A—schizophrenia	0.000203	0.000244	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—GSTM1—schizophrenia	0.000203	0.000244	CbGpPWpGaD
Valsartan—ALB—Transmembrane transport of small molecules—APOA1—schizophrenia	0.000201	0.000242	CbGpPWpGaD
Valsartan—ALB—Metabolism—CACNA1C—schizophrenia	0.000192	0.00023	CbGpPWpGaD
Valsartan—ALB—Metabolism—PIK3C2A—schizophrenia	0.000187	0.000224	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—MTHFR—schizophrenia	0.000179	0.000216	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GAPDH—schizophrenia	0.000177	0.000213	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CLOCK—schizophrenia	0.000176	0.000211	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000175	0.000211	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.000173	0.000208	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TPH2—schizophrenia	0.000171	0.000206	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CACNB2—schizophrenia	0.000171	0.000206	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—DPYD—schizophrenia	0.000169	0.000203	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP2D6—schizophrenia	0.000167	0.000201	CbGpPWpGaD
Valsartan—ALB—Metabolism—SNAP25—schizophrenia	0.000167	0.000201	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOE—schizophrenia	0.000167	0.000201	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—APOA1—schizophrenia	0.000165	0.000198	CbGpPWpGaD
Valsartan—ALB—Platelet activation, signaling and aggregation—AKT1—schizophrenia	0.000157	0.000189	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CACNA1C—schizophrenia	0.000157	0.000188	CbGpPWpGaD
Valsartan—AGTR1—GPCR downstream signaling—AKT1—schizophrenia	0.000153	0.000184	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PIK3C2A—schizophrenia	0.000153	0.000184	CbGpPWpGaD
Valsartan—ALB—Metabolism—CYP1A2—schizophrenia	0.000151	0.000182	CbGpPWpGaD
Valsartan—ALB—Metabolism—TH—schizophrenia	0.000149	0.000179	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—EP300—schizophrenia	0.000142	0.00017	CbGpPWpGaD
Valsartan—AGTR1—Signaling by GPCR—AKT1—schizophrenia	0.000139	0.000167	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—SNAP25—schizophrenia	0.000137	0.000165	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP2D6—schizophrenia	0.000137	0.000165	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—EP300—schizophrenia	0.000136	0.000163	CbGpPWpGaD
Valsartan—ALB—Hemostasis—EP300—schizophrenia	0.000134	0.000161	CbGpPWpGaD
Valsartan—ALB—Metabolism—COMT—schizophrenia	0.000127	0.000152	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTP1—schizophrenia	0.000126	0.000152	CbGpPWpGaD
Valsartan—ALB—Metabolism—MAOA—schizophrenia	0.000126	0.000151	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—CYP1A2—schizophrenia	0.000124	0.000149	CbGpPWpGaD
Valsartan—ALB—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000122	0.000147	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—TH—schizophrenia	0.000122	0.000147	CbGpPWpGaD
Valsartan—ALB—Metabolism—ABCB1—schizophrenia	0.00012	0.000144	CbGpPWpGaD
Valsartan—ALB—Metabolism—GSTM1—schizophrenia	0.000116	0.000139	CbGpPWpGaD
Valsartan—ALB—Metabolism—PLA2G4A—schizophrenia	0.000116	0.000139	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—COMT—schizophrenia	0.000104	0.000125	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTP1—schizophrenia	0.000103	0.000124	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MAOA—schizophrenia	0.000103	0.000124	CbGpPWpGaD
Valsartan—ALB—Metabolism—MTHFR—schizophrenia	0.000103	0.000123	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.0001	0.00012	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—ABCB1—schizophrenia	9.78e-05	0.000118	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—TP53—schizophrenia	9.72e-05	0.000117	CbGpPWpGaD
Valsartan—ALB—Hemostasis—TP53—schizophrenia	9.6e-05	0.000115	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOE—schizophrenia	9.55e-05	0.000115	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—EP300—schizophrenia	9.52e-05	0.000114	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—PLA2G4A—schizophrenia	9.5e-05	0.000114	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—GSTM1—schizophrenia	9.5e-05	0.000114	CbGpPWpGaD
Valsartan—ALB—Metabolism—APOA1—schizophrenia	9.44e-05	0.000113	CbGpPWpGaD
Valsartan—SLCO1B3—Metabolism—AKT1—schizophrenia	8.56e-05	0.000103	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—MTHFR—schizophrenia	8.39e-05	0.000101	CbGpPWpGaD
Valsartan—AGTR1—Signaling Pathways—AKT1—schizophrenia	8.21e-05	9.86e-05	CbGpPWpGaD
Valsartan—ALB—Hemostasis—AKT1—schizophrenia	8.11e-05	9.74e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOE—schizophrenia	7.81e-05	9.39e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—APOA1—schizophrenia	7.72e-05	9.28e-05	CbGpPWpGaD
Valsartan—SLCO1B1—Metabolism—AKT1—schizophrenia	5.75e-05	6.91e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—EP300—schizophrenia	5.44e-05	6.54e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—EP300—schizophrenia	4.45e-05	5.35e-05	CbGpPWpGaD
Valsartan—ALB—Metabolism—AKT1—schizophrenia	3.29e-05	3.95e-05	CbGpPWpGaD
Valsartan—CYP2C9—Metabolism—AKT1—schizophrenia	2.69e-05	3.23e-05	CbGpPWpGaD
